Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?

Detalles Bibliográficos
Autores: Ampudia-Blasco, FJ, Romera, I, Arino, B, Gomis, R
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:España
Institución:INCLIVA
Repositorio:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
OAI Identifier:oai:incliva.fundanetsuite.com:p3546
Acceso en línea:https://incliva.portalinvestigacion.com/publicaciones/3546
Access Level:acceso abierto
id ES_6bffedaffae1f8cc232fc5dc26388d38
oai_identifier_str oai:incliva.fundanetsuite.com:p3546
network_acronym_str ES
network_name_str España
repository_id_str
spelling Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?Ampudia-Blasco, FJRomera, IArino, BGomis, RDOVE MEDICAL PRESS LTD2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://incliva.portalinvestigacion.com/publicaciones/3546International Journal of General MedicineISSN: 11787074reponame:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVAinstname:INCLIVAInglésinfo:eu-repo/semantics/openAccessoai:incliva.fundanetsuite.com:p35462026-06-07T16:35:31Z
dc.title.none.fl_str_mv Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
title Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
spellingShingle Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
Ampudia-Blasco, FJ
title_short Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
title_full Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
title_fullStr Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
title_full_unstemmed Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
title_sort Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
dc.creator.none.fl_str_mv Ampudia-Blasco, FJ
Romera, I
Arino, B
Gomis, R
author Ampudia-Blasco, FJ
author_facet Ampudia-Blasco, FJ
Romera, I
Arino, B
Gomis, R
author_role author
author2 Romera, I
Arino, B
Gomis, R
author2_role author
author
author
publishDate 2017
dc.date.none.fl_str_mv 2017
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://incliva.portalinvestigacion.com/publicaciones/3546
url https://incliva.portalinvestigacion.com/publicaciones/3546
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv DOVE MEDICAL PRESS LTD
publisher.none.fl_str_mv DOVE MEDICAL PRESS LTD
dc.source.none.fl_str_mv International Journal of General Medicine
ISSN: 11787074
reponame:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname:INCLIVA
instname_str INCLIVA
reponame_str r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
collection r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869410237407035392
score 15,812429

Similares en LA Referencia